FDA
- Status: approved
🇺🇸 Systemic and Intra-Thecal Amikacin Therapy in United States
Systemic and Intra-Thecal Amikacin Therapy (Systemic and Intra-Thecal Amikacin Therapy) regulatory status in United States.
Marketing authorisation
Systemic and Intra-Thecal Amikacin Therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Systemic and Intra-Thecal Amikacin Therapy approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Systemic and Intra-Thecal Amikacin Therapy in United States?
Rambam Health Care Campus is the originator. The local marketing authorisation holder may differ — check the official source linked above.